{"Symbol": "ABVC", "AssetType": "Common Stock", "Name": "ABVC Biopharma Inc", "Description": "American BriVision (Holding) Corporation, a clinical-stage biopharmaceutical company, develops drugs and medical devices to meet unmet medical needs in the United States. ", "CIK": "1173313", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "44370 OLD WARM SPRINGS BOULEVARD, FREMONT, CA, UNITED STATES, 94538", "OfficialSite": "https://www.abvcpharma.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "40582800", "EBITDA": "-4880031", "PERatio": "None", "PEGRatio": "None", "BookValue": "0.514", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-0.28", "RevenuePerShareTTM": "0.046", "ProfitMargin": "0", "OperatingMarginTTM": "-1.465", "ReturnOnAssetsTTM": "-0.172", "ReturnOnEquityTTM": "-0.477", "RevenueTTM": "797920", "GrossProfitTTM": "797920", "DilutedEPSTTM": "-0.28", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "1.045", "AnalystTargetPrice": "2.02", "AnalystRatingStrongBuy": "-", "AnalystRatingBuy": "-", "AnalystRatingHold": "-", "AnalystRatingSell": "-", "AnalystRatingStrongSell": "-", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "50.86", "PriceToBookRatio": "3.366", "EVToRevenue": "52.28", "EVToEBITDA": "-1.899", "Beta": "0.225", "52WeekHigh": "5.48", "52WeekLow": "0.46", "50DayMovingAverage": "2.095", "200DayMovingAverage": "2.468", "SharesOutstanding": "24301100", "SharesFloat": "18961700", "PercentInsiders": "10.705", "PercentInstitutions": "3.272", "DividendDate": "2019-05-08", "ExDividendDate": "None"}